# OPTImization of the Dose of tacroliMUS by Bayesian Prediction

> **NCT03465410** · PHASE4 · COMPLETED · sponsor: **NURIA LLOBERAS BLANCH** · enrollment: 96 (actual)

## Conditions studied

- KIDNEY TRANSPLANTATION

## Interventions

- **DRUG:** Standard dosage of Tacrolimus
- **DRUG:** Bayesian Prediction Tacrolimus dosage

## Key facts

- **NCT ID:** NCT03465410
- **Lead sponsor:** NURIA LLOBERAS BLANCH
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-21
- **Primary completion:** 2020-09-21
- **Final completion:** 2020-09-21
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2021-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03465410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03465410, "OPTImization of the Dose of tacroliMUS by Bayesian Prediction". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03465410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*